These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30028634)

  • 21. Use of Masks in Patients with Cystic Fibrosis.
    Zuckerman JB; Saiman L
    Am J Respir Crit Care Med; 2018 Dec; 198(12):1588-1589. PubMed ID: 30235001
    [No Abstract]   [Full Text] [Related]  

  • 22. Segregation and use of nonshared care settings reduce the risk of multiresistant P. aeruginosa infection. Re: Davies et al., "Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation," Pediatr Pulmonol 2003;35:253-256.
    Festini F; Ballarin S; Loganes C
    Pediatr Pulmonol; 2003 Aug; 36(2):171; author reply 172. PubMed ID: 12833499
    [No Abstract]   [Full Text] [Related]  

  • 23. Eradication of Pseudomonas aeruginosa in cystic fibrosis patients.
    Döring G; Taccetti G; Campana S; Festini F; Mascherini M
    Eur Respir J; 2006 Mar; 27(3):653. PubMed ID: 16507869
    [No Abstract]   [Full Text] [Related]  

  • 24. Pseudomonas aeruginosa biofilms in a bronchoalveolar lavage.
    Pusztaszeri M; Aubert JD; Braunschweig R; Mihaescu A
    Diagn Cytopathol; 2009 Nov; 37(11):825. PubMed ID: 19191299
    [No Abstract]   [Full Text] [Related]  

  • 25. Cystic fibrosis. Pseudomonas aeruginosa infection.
    Chang AL
    Ceylon Med J; 2006 Mar; 51(1):34-5. PubMed ID: 16898036
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply to Zuckerman and Saiman: Use of Masks in Patients with Cystic Fibrosis.
    Wood ME; Stockwell RE; Bell SC
    Am J Respir Crit Care Med; 2018 Dec; 198(12):1589-1590. PubMed ID: 30235006
    [No Abstract]   [Full Text] [Related]  

  • 27. Elusiveness of ideal approach to Pseudomonas aeruginosa infection complicating cystic fibrosis.
    Marshall BC; Liou TG
    Lancet; 2000 Aug; 356(9230):613-4. PubMed ID: 10968431
    [No Abstract]   [Full Text] [Related]  

  • 28. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
    Bauernfeind A; Przyklenk B
    Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
    [No Abstract]   [Full Text] [Related]  

  • 29. Cystic fibrosis and pseudomonas infection.
    Lancet; 1983 Jul; 2(8344):257-8. PubMed ID: 6135081
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccinations against Pseudomonas aeruginosa: active and passive alternatives.
    Bellanti JA; Zeligs BJ; Kulczycki LL
    Pediatr Pulmonol Suppl; 1997; 16():269-70. PubMed ID: 9443307
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.
    Valerius NH; Koch C; Høiby N
    Lancet; 1991 Sep; 338(8769):725-6. PubMed ID: 1679870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does pseudomonas cross-infection occur between cystic-fibrosis patients.
    Kelly NM; Fitzgerald MX; Tempany E; O'Boyle C; Falkiner FR; Keane CT
    Lancet; 1982 Sep; 2(8300):688-90. PubMed ID: 6126629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa infection and cystic fibrosis.
    Kato K; Takayama T
    Lancet; 2002 Jan; 359(9302):262. PubMed ID: 11812595
    [No Abstract]   [Full Text] [Related]  

  • 34. Complex Pseudomonas population structure in cystic fibrosis airway infections.
    Workentine M; Surette MG
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1581-3. PubMed ID: 21693712
    [No Abstract]   [Full Text] [Related]  

  • 35. Cystic fibrosis, Pseudomonas aeruginosa, and selective decontamination.
    Dalzell AM; van Saene HK; Heaf DP
    Arch Dis Child; 1990 Dec; 65(12):1365-7. PubMed ID: 2125405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines for preventing infection with Pseudomonas aeruginosa in people with cystic fibrosis.
    Keogan MT; Johansen HK
    Cochrane Database Syst Rev; 2000; (2):CD001399. PubMed ID: 10796780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial: Pseudomonas vaccines.
    Lancet; 1975 Jul; 2(7926):168. PubMed ID: 49756
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiresistant pulmonary infection in cystic fibrosis--prevention is better than cure.
    Smyth A
    Lancet; 2005 Aug 6-12; 366(9484):433-5. PubMed ID: 16084235
    [No Abstract]   [Full Text] [Related]  

  • 40. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives.
    McCallum SJ; Gallagher MJ; Corkill JE; Hart CA; Ledson MJ; Walshaw MJ
    Thorax; 2002 Jun; 57(6):559-60. PubMed ID: 12037234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.